The Hackett Group (HCKT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Q4 2024 revenue was $79.2 million, exceeding guidance, with adjusted EPS of $0.47 and GAAP EPS of $0.12, the latter impacted by non-cash compensation and acquisition expenses.
Growth was driven by strong SAP segment performance and increased GenAI-related revenues, particularly from the AI XPLR and ZBrain platforms and the LeewayHertz acquisition.
GenAI revenues, with higher margins, are becoming a significant driver as clients move from awareness to budgeted projects.
The company is aggressively pivoting to GenAI-enabled transformation, positioning itself as a key architect for clients' AI journeys.
Acquisition of LeewayHertz expanded end-to-end GenAI consulting and implementation capabilities.
Financial highlights
Q4 2024 total revenue: $79.2 million (up from $72.4 million YoY); revenues before reimbursements: $77.5 million.
Adjusted EBITDA: $19.5 million (25.2% of revenues before reimbursements), up from $16.3 million (23%) YoY.
Adjusted net income: $13.6 million, up from $10.8 million YoY; adjusted diluted EPS: $0.47 (vs. $0.39 prior year).
GAAP net income: $3.6 million, down from $7.9 million YoY; diluted EPS: $0.12, impacted by $5.1 million stock price award and $2.3 million LeewayHertz acquisition expenses.
Cash balance at quarter end: $16.4 million; $7 million debt paid down; 117,000 shares repurchased for $3.6 million; $27.5 million remains authorized for repurchases.
Outlook and guidance
Q1 2025 revenue before reimbursements expected at $75.0–$76.5 million.
Global S&BT segment revenue to grow 5–10% YoY, driven by GenAI, offset by declines in OneStream and e-procurement.
Oracle and SAP segments combined expected to decline 8–10% YoY in Q1.
Adjusted diluted EPS guidance for Q1 2025: $0.39–$0.41; adjusted gross margin: 43–44%; adjusted EBITDA margin: 21–22%.
Latest events from The Hackett Group
- Q2 revenue and EPS exceeded guidance, with Gen AI momentum and strong cash flow.HCKT
Q2 20248 Jul 2026 - Revenue fell 11–12% but net income rose on cost controls and AI strategy execution.HCKT
Q1 20266 May 2026 - Annual meeting to vote on director, stock plan amendment, compensation, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Proxy covers director election, compensation, stock plan amendment, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Q4 2025 beat guidance with SAP and GenAI gains, but margins and EBITDA declined year-over-year.HCKT
Q4 202517 Feb 2026 - Q3 revenue and adjusted EPS beat guidance; GenAI growth accelerated by LeewayHertz acquisition.HCKT
Q3 202417 Jan 2026 - Shareholders will vote on director elections, stock plan expansion, executive pay, and auditor ratification.HCKT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, stock plan amendment, compensation, and auditor.HCKT
Proxy Filing2 Dec 2025 - Q2 revenue up 1.6% to $78.9M; Gen AI drives growth, but costs weigh on net income.HCKT
Q2 202523 Nov 2025